AACR-Novocure Cancer Research Grant
Three-year grants of $350,000 support independent investigators conducting innovative research focused on TTFields.
Related Articles
Share Your Story
As a patient, survivor, or caregiver, your story can provide hope and inspiration to someone who’s been diagnosed with cancer or is undergoing therapy.
FDA approves mitomycin intravesical solution for recurrent low-grade
On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent low-grade
Summer 2025 | Cancer Today
Air pollution, both indoors and outdoors, is a leading cause of lung cancer, especially among nonsmokers. by William G. Nelson, MD, PhD After hearing about…
AACR-Waun Ki Hong Award for Outstanding Achievement in Translational and Clinical Cancer Research
This award will recognize a worthy cancer researcher who has conducted highly meritorious translational and clinical cancer research anywhere in the world.
AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research
Overview for AACR Special Conference in Cancer Research: Advances in Ovarian Cancer Research
Reclaiming Childhood, Thanks to Immunotherapy
Isabella Snow Fraser is a survivor of alveolar soft part sarcoma (ASPS) who is keeping her cancer in check through with immunotherapy.
Exclusive Member Opportunity: Call for Emerging Program Topics for AACR Annual Meeting 2026
AACR members have an exclusive opportunity to suggest emerging session topics for the program of the AACR Annual Meeting 2026.
Screening for Early Detection – CPR24
Cancer screening can detect aberrations at the earliest possible stage of development, when the disease may require less aggressive treatments and may be curable.
FDA approves taletrectinib
On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.).
AACR Trailblazer Cancer Research Grants for Early-Stage Investigators
$1,000,000 over three years for tenure-eligible assistant professors worldwide who are working on paradigm-shifting research.